News

Absci Welcomes Mary Szela, a Leader in Biopharma Innovation

Absci Welcomes Mary Szela, a Leader in Biopharma Innovation

Absci Strengthens Leadership with New Board Member

Absci, a pioneering clinical-stage biopharmaceutical company focused on advancing breakthrough therapeutics through generative AI, has announced an important addition to its Board of Directors. Veteran industry leader Mary Szela joins the team, bringing with her a wealth of experience and strategic vision.

Mary Szela's Impressive Background

Mary Szela has a distinguished career in the biopharmaceutical sector, having held key roles that shaped the development and commercialization of significant therapies. Notably, during her time at Abbott Laboratories, she was instrumental in the global launch of Humira, contributing to its expansion into multiple therapeutic areas.

A Vision for the Future

Sean McClain, Founder and CEO of Absci, expressed enthusiasm regarding Szela's appointment, stating, "Mary has been a driving force in bringing successful therapies to market. Her extensive experience will be invaluable as we work on potentially transformative programs like ABS-201 for androgenetic alopecia, and continue to expand our pipeline of innovative AI-designed biologics."

Expertise on the Board

In addition to her role at Absci, Mary Szela currently serves as the Chief Executive Officer and Director of TriSalus Life Sciences, and has board experience with companies such as Prometheus Biosciences, Kura Oncology, and Novo Nordisk. Her strong educational background includes a B.S. in Nursing and an MBA from the University of Illinois at Chicago.

Szela on Absci's Transformation

Reflecting on Absci's journey, Szela remarked, "I have witnessed Absci transition from a data-first platform to a leading force in AI-driven drug discovery. It's exciting to see a growing pipeline of high-potential biologics designed with cutting-edge technology. I'm honored to join at such a critical juncture and eager to contribute to our mission of delivering superior biologics to patients more rapidly."

Development Pipeline Expansion

Under Szela’s influence, Absci aims to continue advancing its AI-designed therapeutic pipeline. This includes the promising ABS-101, targeted at treating inflammatory bowel disease (IBD), with interim data from Phase 1 trials expected soon, and ABS-201, an innovative approach for androgenetic alopecia that is set to enter clinical trials in the near future.

About Absci

Absci is leading the way in the future of drug discovery through generative design. The company's Integrated Drug Creation™ platform combines advanced AI technologies with a robust synthetic biology data engine, allowing for the rapid innovation of therapeutics that tackle challenging medical conditions. Through their unique approach, Absci ensures each development phase is reinforced by robust data and validation in wet labs, resulting in precise and effective therapeutic designs.

With its headquarters in Vancouver, WA, Absci also operates an AI Research Lab in New York City and an Innovation Center in Switzerland. The company collaborates with prominent pharmaceutical and biotech partners, enhancing its pipeline, which includes the development of ABS-101, aimed at IBD, and ABS-201, a potential breakthrough for androgenetic alopecia.

Investor Contact Information

For inquiries, please contact:

Alex Khan
VP, Finance & Investor Relations
investors@absci.com

Media Contact Information

For media inquiries, reach out to:
press@absci.com

Frequently Asked Questions

Who is Mary Szela?

Mary Szela is a seasoned biopharma executive with experience in leading the commercialization of notable treatments like Humira.

What is Absci's specialty?

Absci specializes in advancing drug discovery through generative AI, focusing on creating innovative biologics.

What are the programs mentioned in the article?

The article discusses programs like ABS-201 for androgenetic alopecia and ABS-101 for inflammatory bowel disease.

Where is Absci headquartered?

Absci’s headquarters are located in Vancouver, WA, with additional facilities in New York City and Switzerland.

How can investors contact Absci?

Investors can contact Alex Khan, VP of Finance & Investor Relations, via email at investors@absci.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Biointron's RushDATA™: Speeding Up Antibody Discovery

Updated Category News Views 207

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 157

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
When to Switch Your LLC to S Corp Status: Tips

Updated Category News Views 79

Is Your LLC Ready for the S Corp Leap? Thinking about shifting your LLC to S corporation status? You're not alone—many business owners hit this fork in the road as their enterprise starts rolling in more dough. And if you're scratching your head wondering if this switch makes sense for your venture, listen up because timing and context are everything here. When Should...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 73

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
SPOC Energy's Hiring Push Signals Growth Surge

Updated Category News Views 64

A Growing Workforce for a Growing Demand Here we are, smack dab in a bustling week of business news, and among it, SPOC Energy is ramping up its workforce across Alabama. Now, SPOC isn't any run-of-the-mill operation; this Birmingham-based manufacturer messes around with advanced power conversion systems and motor-control automation—a mouthful, sure, but critical stuff...

Continue Reading
Foreigner to Rock Irvine with Night Ranger in 2027

Updated Category News Views 85

Irvine Set for a Rock Revival Talk about a blast from the past! On March 27, 2027, two titans of the rock world, Foreigner and Night Ranger, are set to ignite Irvine like it's the glory days of arena rock all over again. Hosted at the Great Park Live, this show isn't just a concert—it's a full-scale invasion of rock's golden age right into Southern California's heart....

Continue Reading
Philip Scroggie's Legacy in Global Energy Projects

Updated Category News Views 116

A Lifetime of Energy Industry Excellence When you've been around the block in the energy sector as long as Philip D. Scroggie has, you're bound to pick up a few accolades. Recognized as an Inner Circle Lifetime Member, this guy has etched his name in the annals of global energy project management. Yeah, he's been a heavyweight in the oil, gas, and LNG industries, and he's...

Continue Reading
TruGreen Finds New Growth in Birch Hill Acquisition

Updated Category News Views 204

TruGreen's New Chapter Begins In the world of lawn care, TruGreen is sowing the seeds for a revitalized future, courtesy of its recent acquisition by Birch Hill Equity Partners. Based out of Franklin, Tennessee, this powerhouse in the green arena is set to start a fresh chapter, swapping partners like old gloves after a long, 19-year stint with Clayton, Dubilier & Rice...

Continue Reading
The Melt Expands with Key Texas Franchise Deal

Updated Category News Views 130

Throwing Down the Gauntlet: The Melt Expands If there's one thing I've learned after decades watching these restaurant chains multiply like rabbits it’s this: when a veteran gets involved, you perk up. The Melt has done just that by roping in Syed Ahmad—a name that actually means something in this game—to open eight new locations in the Lone Star State. It isn't...

Continue Reading
ADI Global Faces Investor Investigation Over Major Write-Down

Updated Category News Views 60

Towering Goodwill Falls and Investor Scrutiny Well, let's dig into this mess ADI Global Distribution has found itself in. If you were hanging onto ADIG shares, your portfolio probably took quite the hit when they revealed a nasty $659 million goodwill write-down. Imagine opening up those financials and seeing about 62% of goodwill value wiped out overnight. Suddenly, that...

Continue Reading

Top 5 Most Recently Viewed Articles

Arvinas Reflects on Successful Year, Projecting Future Growth

Updated Category News Views 220

Arvinas' Notable Advances in 2024 Arvinas, Inc. (Nasdaq: ARVN), a pioneering clinical-stage biotechnology company, continues on its ambitious path, showing significant progress in 2024. The company has been steadfast in its mission to develop innovative therapies targeting debilitating diseases through its unique PROTAC platform. Their latest advancements signal a...

Continue Reading
Understanding NB Private Equity Partners and Their Recent Buyback

Updated Category News Views 256

NB Private Equity Partners Publishes Share Buyback Details Today, NB Private Equity Partners, commonly referred to as NBPE, has made significant strides to enhance its shareholders' value through a recent buyback of its Class A shares. This transaction, carried out in accordance with the general authority bestowed upon the company’s management by shareholders, showcases...

Continue Reading
China’s AI Innovations Enhance Global Development Efforts

Updated Category News Views 385

China’s Commitment to AI Development In recent years, China has made significant strides in artificial intelligence (AI) development, showcasing its dedication to fostering technological innovation and bolstering cooperation with nations around the world. One of the central aspects of this commitment was highlighted during a recent inspection tour by Chinese President...

Continue Reading
Exploring Crypto-Bound Stocks: A Guide to Peak Investments

Updated Category News Views 209

Bitcoin and Ethereum Driving Market Momentum Recently, Bitcoin experienced a significant breakout, surpassing its previous all-time high of around $112,000 and hitting new heights above $123,000. Although it has cooled off somewhat, it remains consolidated just above its previous resistance level, which now functions as a key support zone. With Bitcoin's year-to-date...

Continue Reading
Verra Mobility's Plunge: A 45% Stock Drop Shakes Investors

Updated Category News Views 147

Surprise Hit: Verra Mobility Takes a Blow Verra Mobility's situation feels like having a rug yanked out from under one's feet. The company sent its shareholders into a tailspin after disclosing a major hit: losing a contract with Avis, which accounted for more than 10% of its annual revenue. We're talking about a stock that nosedived roughly 45%—it's the kind of...

Continue Reading